Loading...

Deutsche Cannabis

DB:FAM2
Snowflake Description

Mediocre balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FAM2
DB
€12M
Market Cap
  1. Home
  2. DE
  3. Media
Company description

Deutsche Cannabis AG, together with its subsidiaries, engages in producing, marketing, and trading film, Internet, video, and music productions in Germany and internationally. The last earnings update was 205 days ago. More info.


Add to Portfolio Compare Print
FAM2 Share Price and Events
7 Day Returns
0.8%
DB:FAM2
-0.1%
DE Entertainment
1%
DE Market
1 Year Returns
-36.7%
DB:FAM2
12.1%
DE Entertainment
-5.6%
DE Market
FAM2 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Deutsche Cannabis (FAM2) 0.8% -8.9% 3.1% -36.7% - -
DE Entertainment -0.1% 6.5% 12.7% 12.1% 35.3% 74.8%
DE Market 1% 6.1% 8.4% -5.6% 10.9% 13.8%
1 Year Return vs Industry and Market
  • FAM2 underperformed the Entertainment industry which returned 12.1% over the past year.
  • FAM2 underperformed the Market in Germany which returned -5.6% over the past year.
Price Volatility
FAM2
Industry
5yr Volatility vs Market

FAM2 Value

 Is Deutsche Cannabis undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Deutsche Cannabis. This is due to cash flow or dividend data being unavailable. The share price is €0.665.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Deutsche Cannabis's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Deutsche Cannabis's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:FAM2 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2017-12-31) in EUR €-0.02
DB:FAM1 Share Price ** DB (2019-04-24) in EUR €1.31
Germany Entertainment Industry PE Ratio Median Figure of 10 Publicly-Listed Entertainment Companies 19.65x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.72x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Deutsche Cannabis.

DB:FAM2 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= DB:FAM1 Share Price ÷ EPS (both in EUR)

= 1.31 ÷ -0.02

-56.85x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Deutsche Cannabis is loss making, we can't compare its value to the DE Entertainment industry average.
  • Deutsche Cannabis is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Deutsche Cannabis's expected growth come at a high price?
Raw Data
DB:FAM2 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -56.85x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Entertainment Industry PEG Ratio Median Figure of 30 Publicly-Listed Entertainment Companies 1.71x
Germany Market PEG Ratio Median Figure of 269 Publicly-Listed Companies 1.58x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Deutsche Cannabis, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Deutsche Cannabis's assets?
Raw Data
DB:FAM2 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2017-12-31) in EUR €0.59
DB:FAM1 Share Price * DB (2019-04-24) in EUR €1.31
Germany Entertainment Industry PB Ratio Median Figure of 14 Publicly-Listed Entertainment Companies 1.56x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.87x
DB:FAM2 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= DB:FAM1 Share Price ÷ Book Value per Share (both in EUR)

= 1.31 ÷ 0.59

2.23x

* Primary Listing of Deutsche Cannabis.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Deutsche Cannabis is overvalued based on assets compared to the DE Entertainment industry average.
X
Value checks
We assess Deutsche Cannabis's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Entertainment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Entertainment industry average (and greater than 0)? (1 check)
  5. Deutsche Cannabis has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FAM2 Future Performance

 How is Deutsche Cannabis expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Deutsche Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
23%
Expected Entertainment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Deutsche Cannabis expected to grow at an attractive rate?
  • Unable to compare Deutsche Cannabis's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Deutsche Cannabis's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Deutsche Cannabis's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:FAM2 Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Entertainment Industry Earnings Growth Rate Market Cap Weighted Average 23%
Germany Entertainment Industry Revenue Growth Rate Market Cap Weighted Average 3.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:FAM2 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 year ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:FAM2 Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2017-12-31 0 0
2016-12-31 0 0
2016-06-30 0 0
2016-03-31 0 0
2015-12-31 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Deutsche Cannabis is high growth as no earnings estimate data is available.
  • Unable to determine if Deutsche Cannabis is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:FAM2 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 year ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Deutsche Cannabis Company Filings, last reported 1 year ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:FAM2 Past Financials Data
Date (Data in EUR Millions) EPS *
2017-12-31 -0.02
2016-12-31 0.00
2016-06-30 -0.01
2016-03-31 -0.02
2015-12-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Deutsche Cannabis will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Deutsche Cannabis's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Media companies here
  2. Deutsche Cannabis's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Deutsche Cannabis's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Deutsche Cannabis has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FAM2 Past Performance

  How has Deutsche Cannabis performed over the past 5 years?

  • Deutsche Cannabis's last earnings update was 205 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Deutsche Cannabis's growth in the last year to its industry (Entertainment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Deutsche Cannabis does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Deutsche Cannabis's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Deutsche Cannabis's 1-year growth to the DE Entertainment industry average as it is not currently profitable.
Earnings and Revenue History
Deutsche Cannabis's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Deutsche Cannabis Company Filings, last reported 1 year ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:FAM2 Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2017-12-31 -0.14
2016-12-31 0.00
2016-06-30 -0.02 0.00
2016-03-31 -0.06 0.00
2015-12-31 -0.10 0.00
2014-12-31 -0.37 0.01
2013-12-31 -0.11

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Deutsche Cannabis has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Deutsche Cannabis has efficiently used its assets last year compared to the DE Entertainment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Deutsche Cannabis improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Deutsche Cannabis's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Entertainment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Deutsche Cannabis has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FAM2 Health

 How is Deutsche Cannabis's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Deutsche Cannabis's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Deutsche Cannabis is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Deutsche Cannabis has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Deutsche Cannabis's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 18.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Deutsche Cannabis Company Filings, last reported 1 year ago.

DB:FAM2 Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2017-12-31 3.68 0.04 0.32
2016-12-31 1.33 0.05 0.17
2016-06-30 0.00 0.02 0.17
2016-03-31 0.00 0.02 0.17
2015-12-31 0.00 0.02 0.17
2014-12-31 -0.21 0.00 0.02
2013-12-31 0.05 0.00 0.34
  • Deutsche Cannabis's level of debt (1.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Deutsche Cannabis's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Deutsche Cannabis has less than a year of cash runway based on current free cash flow.
  • Deutsche Cannabis has less than a year of cash runway if free cash flow continues to grow at historical rates of 165.1% each year.
X
Financial health checks
We assess Deutsche Cannabis's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Deutsche Cannabis has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FAM2 Dividends

 What is Deutsche Cannabis's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Deutsche Cannabis dividends.
If you bought €2,000 of Deutsche Cannabis shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Deutsche Cannabis's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Deutsche Cannabis's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:FAM2 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Entertainment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.5%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Deutsche Cannabis has not reported any payouts.
  • Unable to verify if Deutsche Cannabis's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Deutsche Cannabis's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Deutsche Cannabis has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Deutsche Cannabis's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Deutsche Cannabis afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Deutsche Cannabis has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FAM2 Management

 What is the CEO of Deutsche Cannabis's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • Deutsche Cannabis has no CEO, or we have no data on them.
Management Team

Lawrence Lotman

TITLE
Vice President of Finance & Secretary
AGE
70

Holger Uhrhammer

TITLE
Member of Management Board

André Müller

TITLE
Member of Management Board

Mathew Mitchell

TITLE
Investor Relations Consultant
TENURE
14.8 yrs
Board of Directors

Matthias Winkler

TITLE
Chairman of Supervisory Board

Marco Schulze

TITLE
Deputy Chairman of the Supervisory Board

Randy Shipley

TITLE
Member of Supervisory Board
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Deutsche Cannabis's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Deutsche Cannabis has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FAM2 News

Simply Wall St News

FAM2 Company Info

Description

Deutsche Cannabis AG, together with its subsidiaries, engages in producing, marketing, and trading film, Internet, video, and music productions in Germany and internationally. The company operates in two divisions, Film Production and Music Production. The Film Production division produces films from scriptwriting and shooting to the marketing of films through various distribution partners, including cinema distributors and international sales partners, as well as through television channels. It also trades film rights and acts as a co-producer of films made by other companies. The Music Production division produces music for movies, shows, and serials on television, as well as for feature films. It also develops, produces, and markets recording artists. The company was formerly known as F.A.M.E. AG and changed its name to Deutsche Cannabis AG in December 2014. Deutsche Cannabis AG is based in Berlin, Germany.

Details
Name: Deutsche Cannabis AG
FAM2
Exchange: DB
Founded:
€11,886,121
9,073,375
Website: http://www.deutschecannabis.com
Address: Deutsche Cannabis AG
Wittestrasse 30E,
Berlin,
Berlin, 13509,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
DB FAM1 Bearer Common Stock Deutsche Boerse AG DE EUR 31. Aug 2000
XTRA FAM1 Bearer Common Stock XETRA Trading Platform DE EUR 31. Aug 2000
LSE 0EF9 Bearer Common Stock London Stock Exchange GB EUR 31. Aug 2000
DB FAM2 NPV Deutsche Boerse AG DE EUR 16. Dec 2016
XTRA FAM2 NPV XETRA Trading Platform DE EUR 16. Dec 2016
LSE 0RL7 NPV London Stock Exchange GB EUR 16. Dec 2016
Number of employees
Current staff
Staff numbers
0
Deutsche Cannabis employees.
Industry
Movies and Entertainment
Media
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/24 23:08
End of day share price update: 2019/04/24 00:00
Last earnings filing: 2018/10/01
Last earnings reported: 2017/12/31
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.